Table 3.

Impact of Panton-Valentine leukocidin (PVL) (lukF-PV/lukS-PV) and β-haemolysin (hlb) on SSTI.

Characteristics (n)	lukF-PV/lukS-PV			hlb positive (n = 23)			lukF-PV/lukS-PV and hlb
	positive (n = 37)						positive (n = 19)
	N	OR (95% CI)	P-value	N	OR (95% CI)	P-value	N	OR (95% CI)	P-value
Abscess and furuncles (46)	28	4.9 (1.8–13.3)	0.002	18	4.1 (1.3–12.7)	0.02	16	5.7 (1.5–21.7)	0.01
Recurrent infection (12)	10	7.7 (1.5–39.7)	0.02	7	4.6 (1.2–17)	0.02	7	6.26 (1.63,23.99)	0.007

OR (95% CI) and P-value are adjusted for age, comorbidities (Charlson comorbidity score) and effective antimicrobial therapy on day 1.